These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A reversible disorder of the avoidance reaction as an experimental model for the study of the action of psychotropic preparations on higher nervous activity]. Inozemtsev AN; Pragina LL Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(4):764-6. PubMed ID: 2816063 [No Abstract] [Full Text] [Related]
4. [Psychotropic properties of corticotropin and its analogs]. Tikhomirov SM; Bakharev VD Probl Endokrinol (Mosk); 1986; 32(1):46-9. PubMed ID: 3006019 [TBL] [Abstract][Full Text] [Related]
5. [Effect of antioxidants and nootropic agents on the duration of ketamine general anesthesia and on the course of the postanesthesia period]. Uvarov BS; Vorob'ev AA; Uriupov OIu; Katkov VF; Katkova EB Anesteziol Reanimatol; 1987; (5):3-6. PubMed ID: 3434868 [No Abstract] [Full Text] [Related]
6. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs? Obuchowicz E; Krysiak R; Herman ZS Neurosci Biobehav Rev; 2004 Oct; 28(6):595-610. PubMed ID: 15527865 [TBL] [Abstract][Full Text] [Related]
7. [The neuropharmacological correction of cognitive processes disordered as a result of the extirpation of fields AI-AII and Ep in cats]. Mukhin EI Fiziol Zh Im I M Sechenova; 1995 Jan; 81(1):56-64. PubMed ID: 7489015 [No Abstract] [Full Text] [Related]
8. [The nooglutil correction of functional disorders of the central nervous system caused by prenatal alcoholization in rats]. Trofimov SS; Ostrovskaia RU; Smol'nikova NM; Khromova IV; Krapivin SV; Krylova AM; Kovalev GI; Gaĭnetdinov RR; Liubimov BI; Voronina TA Eksp Klin Farmakol; 1992; 55(1):18-21. PubMed ID: 1305426 [TBL] [Abstract][Full Text] [Related]
9. [Interaction of psychotropic preparations and ethanol]. Saratikov AS; Vengerovskiĭ AI; Skakun NP; Oleĭnik AN Farmakol Toksikol; 1985; 48(3):123-6. PubMed ID: 2863168 [No Abstract] [Full Text] [Related]
10. A protocol for the evaluation of new psychoactive drugs in man. Shulgin AT; Shulgin LA; Jacob P Methods Find Exp Clin Pharmacol; 1986 May; 8(5):313-20. PubMed ID: 3724306 [TBL] [Abstract][Full Text] [Related]
11. Stereochemical considerations of the actions of some psychotropic drugs. Smith DF Pharmacopsychiatry; 1985 May; 18(3):225-30. PubMed ID: 2861608 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of psychotropic drug response. Malhotra AK; Murphy GM; Kennedy JL Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641 [TBL] [Abstract][Full Text] [Related]
14. Potential for oxytocin use in children and adolescents with mental illness. Netherton E; Schatte D Hum Psychopharmacol; 2011; 26(4-5):271-81. PubMed ID: 21751251 [TBL] [Abstract][Full Text] [Related]
16. Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients. Davis JM J Geriatr Psychiatry; 1974; 7(2):145-59. PubMed ID: 4155416 [No Abstract] [Full Text] [Related]
17. [Use of the conditioned avoidance reflex for detecting potential stimulants of higher nervous activity and their comparative characteristics]. Vinogradov VM; Grechko AT Farmakol Toksikol; 1982; 45(4):5-9. PubMed ID: 7128785 [TBL] [Abstract][Full Text] [Related]
18. Determination of pharmacodynamics of psychotropic drugs by psychometric analysis. Grünberger J; Saletu B Prog Neuropsychopharmacol; 1980; 4(4-5):417-34. PubMed ID: 6111814 [No Abstract] [Full Text] [Related]
19. Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats. Fatemi SH; Folsom TD; Reutiman TJ; Pandian T; Braun NN; Haug K Schizophr Res; 2008 Sep; 104(1-3):127-34. PubMed ID: 18585900 [TBL] [Abstract][Full Text] [Related]
20. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Hyman SE; Nestler EJ Am J Psychiatry; 1996 Feb; 153(2):151-62. PubMed ID: 8561194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]